BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6138819)

  • 1. Evidence for a role of endogenous opiates in postprandial somatostatin release.
    Schusdziarra V; Rewes B; Lenz N; Maier V; Pfeiffer EF
    Regul Pept; 1983 Aug; 6(4):355-61. PubMed ID: 6138819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbohydrates modulate opiate receptor mediated mechanisms during postprandial endocrine function.
    Schusdziarra V; Rewes B; Lenz N; Maier V; Pfeiffer EF
    Regul Pept; 1983 Nov; 7(3):243-52. PubMed ID: 6141625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of naloxone on pancreatic and gastric endocrine function in response to carbohydrate and fat-rich test meals.
    Schusdziarra V; Holland A; Maier V; Pfeiffer EF
    Peptides; 1984; 5(1):65-71. PubMed ID: 6143305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory effect of glucose, amino acids, and secretin on CCK-8-induced somatostatin and pancreatic polypeptide release in dogs.
    Schusdziarra V; Lenz N; Schick R; Maier V
    Diabetes; 1986 May; 35(5):523-9. PubMed ID: 2869995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous opioids modulate the effect of cholecystokinin on insulin release in dogs.
    Schusdziarra V; Lenz N; Rewes B; Pfeiffer EF
    Neuropeptides; 1984 Nov; 4(6):507-17. PubMed ID: 6096758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of motilin-induced somatostatin release in dogs by naloxone.
    Schick R; Schusdziarra V
    Peptides; 1985; 6(5):861-4. PubMed ID: 2867525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of histamine H2-receptor stimulation on postprandial pancreatic and gastric endocrine function in dogs.
    Schusdziarra V; Stapelfeldt W; Klier M; Maier V; Pfeiffer EF
    Res Exp Med (Berl); 1982; 181(3):253-7. PubMed ID: 6131510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central and peripheral control of postprandial pyloric motility by endogenous opiates and cholecystokinin in dogs.
    Lopez Y; Fioramonti J; Bueno L
    Gastroenterology; 1991 Nov; 101(5):1249-55. PubMed ID: 1936795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of beta-casomorphins on somatostatin release in dogs.
    Schusdziarra V; Schick R; de la Fuente A; Holland A; Brantl V; Pfeiffer EF
    Endocrinology; 1983 Jun; 112(6):1948-51. PubMed ID: 6133741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous opioid modulation of pancreatic hormone secretion: studies in dogs.
    Levin ER; Yamada T; Levin S; Mills S
    Metabolism; 1986 Jan; 35(1):59-63. PubMed ID: 2867455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of endogenous opiates in glucose-stimulated hyperinsulinism of canine endotoxin shock. Inhibition by naloxone.
    Merrill GA; Anderson JH
    Diabetes; 1987 May; 36(5):585-91. PubMed ID: 2952536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulation of basal pancreatic polypeptide levels in dogs.
    Werther GA; Sperling MA; Joffe S; Murphy RF
    Regul Pept; 1987 Apr; 17(4):191-8. PubMed ID: 2884699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate dependent stimulation of insulin and glucagon but not gastrin and somatostatin release during the intestinal phase of a meal.
    Schusdziarra V; Dangel G; Henrichs I; Klier M; Pfeiffer EF
    Horm Metab Res; 1982 Apr; 14(4):169-71. PubMed ID: 6123480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of opiate-receptor blockade on normoglycemic and hypoglycemic glucoregulation.
    el-Tayeb KM; Brubaker PL; Lickley HL; Cook E; Vranic M
    Am J Physiol; 1986 Mar; 250(3 Pt 1):E236-42. PubMed ID: 3006509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of physiological increments of blood glucose on plasma somatostatin and pancreatic polypeptide levels in dogs.
    Schusdziarra V; Stapelfeldt W; Klier M; Maier V; Pfeiffer EF
    Regul Pept; 1981 Aug; 2(4):211-8. PubMed ID: 6116261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin-14 modulates postprandial glucose levels and release of gastrointestinal and pancreatic hormones.
    O'Shaughnessy DJ; Long RG; Adrian TE; Christofides ND; Ghatei MA; Sarson DL; Bloom SR
    Digestion; 1985; 31(4):234-42. PubMed ID: 2861129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of soy polysaccharide on postprandial plasma glucose, insulin, glucagon, pancreatic polypeptide, somatostatin, and triglyceride in obese diabetic patients.
    Tsai AC; Vinik AI; Lasichak A; Lo GS
    Am J Clin Nutr; 1987 Mar; 45(3):596-601. PubMed ID: 2881482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress-induced changes in gastric emptying, postprandial motility, and plasma gut hormone levels in dogs.
    Gué M; Peeters T; Depoortere I; Vantrappen G; Buéno L
    Gastroenterology; 1989 Nov; 97(5):1101-7. PubMed ID: 2571543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opiate modulation of pancreatic polypeptide release by a meal in the dog.
    Materia A; Modlin IM; Sank AC; Albert D; Jaffe BM
    J Pharmacol Exp Ther; 1982 Nov; 223(2):355-8. PubMed ID: 7131290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of insulin and glucagon secretion by opiates: a study with naloxone in healthy humans.
    Locatelli A; Spotti D; Caviezel F
    Acta Diabetol Lat; 1985; 22(1):25-31. PubMed ID: 3890450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.